Physitrack Q1 2025 Preview: Early indications of enhanced profitability anticipated - Redeye

We expect Physitrack’s ongoing streamlining and consolidation efforts to begin bearing fruit in Q1 2025. With the divestment of lower-margin activities and the rollout of its cost-efficiency program, margin expansion should start to materialise this quarter.

Länk till analysen i sin helhet: https://www.redeye.se/research/1095227/physitrack-q1-2025-preview-early-indications-of-enhanced-profitability-anticipated?utm_source=finwire&utm_medium=RSS